Zwei Cannabinoid-BlƤtter – Symbol für die CB1- und CB2-Rezeptoren im Endocannabinoid-System

Cannabinoid Receptors: What CB1 and CB2 Really Do in Your Body

Written by: Anne Ullrich

|

Time to read 6 min

The human body's Endocannabinoid System (ECS) is a complex network of receptors, signaling molecules, and enzymes that plays a central role in regulating numerous physiological processes. From pain perception to the immune system and influencing our mood, the ECS plays many roles in our daily lives.

At the heart of the system are the cannabinoid receptors CB1 and CB2, which interact with endogenous (body-produced) and external cannabinoids (e.g., CBD, THC). But how exactly do these receptors work, and why are they so important for our health?

In this article, we take a comprehensive look at the various cannabinoid receptors and their significance. We explain which cannabinoids act on which receptors and present current findings from cannabinoid research.

The most important things at a glance

CB1 and CB2 are the central receptors in the Endocannabinoid System (ECS). The ECS regulates the body's balance in all vertebrates.

Cannabinoids like THC and CBD interact with receptors similarly to endogenous cannabinoids, influencing stress, pain perception, inflammation, and much more.

Research is keenly investigating how CB1 and CB2 receptors can be specifically influenced. If successful, this could revolutionize medicine, from pain therapy to general improvement of mental and physical health.

High-quality CBD oils from hanfgeflüster

The Endocannabinoid System and Its Functions

The ECS is an evolutionarily ancient regulatory system found in all vertebrates, including humans. It consists of three main components:

  1. Cannabinoid receptors (CB1 and CB2) are binding sites for cannabinoids such as THC, CBD, and others.

  2. Endocannabinoids: Molecules like anandamide and 2-arachidonoylglycerol (2-AG) that send endogenous signals to the receptors. (The term "endo" refers to these cannabinoids being body-produced.)

  3. Enzymes: These break down endocannabinoids after use.

The primary function of the ECS is to maintain homeostasis, meaning balance in the body. This balance is crucial for functions such as:

Cannabinoid Receptors CB1 and CB2 in the Endocannabinoid System

The Two Main Types of Cannabinoid Receptors

CB1 Receptors

CB1 receptors are mainly found in the central nervous system (CNS), i.e., in the brain (especially the hippocampus) and spinal cord. There, they influence signal transmission between neurons and play a central role in controlling motor skills, memory and learning, appetite regulation, and pain perception.

CB2 Receptors

CB2 receptors are primarily located in the immune system and peripheral tissues such as the skin and organs. They are responsible for regulating inflammatory and immunological processes.

A Look into Evolution: Why do we even have Cannabinoid Receptors?

The body's own cannabinoid system appears to be evolutionarily very old – this is indicated, among other things, by the fact that it occurs in all vertebrates, including mammals, birds, fish, and even reptiles. Evolutionarily speaking, endocannabinoids serve to regulate vital functions and respond to stressors. In the event of material imbalances in the body – for example, stress or anxiety – endogenous cannabinoids (endocannabinoids) are released. They bind to the corresponding receptors and regulate the activity of nerve cells, thus balancing the imbalance.

The ECS therefore likely evolved to coordinate and regulate complex physiological functions in vertebrates with the help of endocannabinoids. The ability to alleviate pain or control inflammation proved to be an evolutionary advantage and was passed on.

Sounds interesting?

Try CBD Oil now.

Discover CBD Oils now

How CBD and THC act on cannabinoid receptors

THC, a psychoactive cannabinoid from the cannabis plant, binds directly to CB1 receptors. Without the influence of stressors or other factors, it thus alters their activity and disrupts their normal function. This can result in pain inhibition, euphoria ("high"), but also negative feelings (depression, anxiety, hallucinations) or even severe side effects like drug-induced psychoses. It is not possible to predict in advance how the respective organism will react to cannabis consumption.

CBD (cannabidiol), on the other hand, acts indirectly, primarily on CB2 receptors. It does not bind to them, but rather modulates their activity and inhibits the breakdown of endogenous cannabinoids. In this way, it influences the concentration of the respective endocannabinoids in the body. Scientists assume that the diverse positive effects of CBD are due to this interaction with CB2 receptors.

Chemische Struktur von THC und CBD

The Significance of Cannabinoid Receptors - What Research Says

According to studies, the targeted influence of CB1 and CB2 receptors holds great potential for the treatment of various symptoms:

  • Pain therapy:
    THC and CBD have proven effective against chronic pain in studies¹. While THC has pain-inhibiting effects by activating CB1 receptors, CBD modulates inflammatory processes and can thus also have pain-relieving effects.

  • Inflammatory diseases:
    CB2 receptors play a crucial role in regulating inflammatory processes. CBD could therefore be helpful in conditions such as arthritis, inflammatory bowel diseases like Crohn's disease or diabetes type 1 and type 2.

  • Anxiety and sleep disorders:
    The modulation of CB1 receptors by CBD appears to have anxiolytic and sleep-promoting effects, without causing psychoactive side effects.²

  • Neurodegenerative diseases:
    Studies³ suggest that the activation of CB1 and CB2 receptors could have neuroprotective effects. This is particularly interesting for diseases such as Alzheimer's and Parkinson's.

CBD is now even gaining attention in cancer research. CB2 receptors appear to play a role in inhibiting tumor cells. Studies⁓ are investigating whether cannabinoids can slow the growth of certain types of cancer.

CBD is also being explored with great interest for the treatment of chemotherapy side effects. For example, a recent study in rats⁵ investigated whether cannabidiol (CBD) can alleviate side effects of chemotherapy with doxorubicin (DOX). DOX typically causes side effects such as anxiety, depression, and memory problems, which often persist even after chemotherapy. CBD showed a significant calming effect and positively influenced the changes in the brain caused by DOX.

Cannabinoids for animals

Since all vertebrates also have an endocannabinoid system with CB1 and CB2 receptors, they too can benefit from the application of CBD. In dogs, cats, and other mammals, these receptors also play a role in pain regulation and the function of the immune system. It's no wonder that CBD products for pets are becoming increasingly popular.

Our Conclusion: Cannabinoid Receptors with Incredible Potential

Research into the endocannabinoid system and its receptors is still in its early stages for many questions. Our nervous system is very complex, and the (inter-)actions of the various substances are incredibly diverse.

One thing is certain: the targeted influencing of CB1 and CB2 receptors could mean a revolution in medicine – from pain therapy to the treatment of neurodegenerative diseases and the improvement of general physical and mental well-being.

Cannabinoids from the hemp plant with particularly low side effects, such as CBD, are particularly promising, as they hold great potential for positive effects without negative consequences.

Customer reviews:

"Everything perfect! Good products, fast delivery, excellent service. In case of a complaint, contact via WhatsApp is possible. They reacted quickly and found a good solution for me. I can only recommend Hanfgeflüster products and service!"

Ute, January 24, 2025

Discover our full-spectrum CBD oils

Sounds interesting?

Try CBD oil now.

Discover CBD oils now

Sources and Studies

¹ Hameed, M., Prasad, S., Jain, E., Dogrul, B. N., Al-Oleimat, A., Pokhrel, B., Chowdhury, S., Co, E. L., Mitra, S., Quinonez, J., Ruxmohan, S., & Stein, J. (2023). Medical Cannabis for Chronic Nonmalignant Pain Management. Current pain and headache reports, 27(4), 57–63.

² Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 12(4), 825–836.

³ Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022). A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic & clinical pharmacology & toxicology, 130(4), 439–456.

⁓ Lal, S., Shekher, A., Puneet, Narula, A. S., Abrahamse, H., & Gupta, S. C. (2021). Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities. Pharmacological research, 163, 105302.

⁵ Poudel, B., Bany, B. M., Hales, D. B., & Cheatwood, J. L. (2024). Effects of Cannabidiol (CBD) on Doxorubicin-Induced Anxiety and Depression-like Behaviors and mRNA Expression of Inflammatory Markers in Rats. Brain sciences, 14(10), 999.